ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 23 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $59,000 | +28.3% | 59,000 | +31.1% | 0.00% | 0.0% |
| Q1 2021 | $46,000 | 0.0% | 45,000 | +4.7% | 0.00% | 0.0% |
| Q4 2020 | $46,000 | -2.1% | 43,000 | -4.4% | 0.00% | 0.0% |
| Q3 2020 | $47,000 | -4.1% | 45,000 | +2.3% | 0.00% | 0.0% |
| Q2 2020 | $49,000 | +8.9% | 44,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $45,000 | -10.0% | 44,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $50,000 | -3.8% | 44,000 | -4.3% | 0.00% | 0.0% |
| Q3 2019 | $52,000 | -7.1% | 46,000 | -2.1% | 0.00% | 0.0% |
| Q2 2019 | $56,000 | -5.1% | 47,000 | +6.8% | 0.00% | 0.0% |
| Q1 2019 | $59,000 | +18.0% | 44,000 | -6.4% | 0.00% | 0.0% |
| Q4 2018 | $50,000 | -5.7% | 47,000 | -6.0% | 0.00% | 0.0% |
| Q3 2018 | $53,000 | +12.8% | 50,000 | +4.2% | 0.00% | 0.0% |
| Q2 2018 | $47,000 | +6.8% | 48,000 | +6.7% | 0.00% | 0.0% |
| Q1 2018 | $44,000 | -10.2% | 45,000 | -2.2% | 0.00% | 0.0% |
| Q4 2017 | $49,000 | 0.0% | 46,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $49,000 | -5.8% | 46,000 | -6.1% | 0.00% | 0.0% |
| Q2 2017 | $52,000 | +10.6% | 49,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $47,000 | – | 49,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Man Investments (CH) AG | 7,000,000 | $6,536,000 | 3.36% |
| Sonora Investment Management, LLC | 15,550,000 | $14,486,691,000 | 3.04% |
| Jabre Capital Partners S.A. | 7,550,000 | $7,050,000 | 0.96% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 70,972,000 | $66,281,000 | 0.96% |
| MACKAY SHIELDS LLC | 10,243,000 | $9,558,000 | 0.43% |
| ARISTEIA CAPITAL, L.L.C. | 7,500,000 | $6,998,000 | 0.38% |
| OAKTREE CAPITAL MANAGEMENT LP | 27,100,000 | $25,384,000 | 0.33% |
| SSI INVESTMENT MANAGEMENT LLC | 2,671,000 | $2,485,000 | 0.22% |
| Verition Fund Management LLC | 2,000,000 | $1,866,000 | 0.20% |
| PALISADE CAPITAL MANAGEMENT, LP | 5,849,000 | $5,453,000 | 0.19% |